Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 12721-12730 of 13618

Page
per page
  1. Reversan
    B7485 Reversan
    Summary: inhibitor of multidrug resistance-associated protein 1 (MRP1) and P-glycoprotein (P-gp)
      <11.04 mg/mL
  2. NPEC-caged-D-AP5
    B7623 NPEC-caged-D-AP5
    Summary: NMDA receptor antagonist
      <39.03 mg/mL
  3. KRCA 0008
    B7749 KRCA 0008
    Summary: Ack1 and anaplastic lymphoma kinase (ALK) dual inhibitor
      Soluble in DMSO
  4. H-9 dihydrochloride
    B5001 H-9 dihydrochloride
    Summary: A protein kinase inhibitor that inhibits PKA activity and interferes with EGF signaling.
      Soluble in DMSO
  5. FCCP
    B5004 FCCP
     8 Citation
    Summary: uncoupler of oxidative phosphorylation
  6. 7-NINA
    B5019 7-NINA
    Summary: non-selective NOS inhibitor
      <9.26 mg/mL
  7. Vemurafenib (PLX4032, RG7204)
    A3004 Vemurafenib (PLX4032, RG7204)
     13 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥24.5 mg/mL
  8. GDC-0068 (RG7440)
    A3006 GDC-0068 (RG7440)
     3 Citation
    Target: Akt
    Summary: Pan-AKT inhibitor,highly selective
      ≥22.9 mg/mL
  9. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     32 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor
      ≥23.27 mg/mL
  10. GDC-0449 (Vismodegib)
    A3021 GDC-0449 (Vismodegib)
     12 Citation
    Target: P-glycoprotein (P-gp)|Hedgehog
    Summary: Hedgehog antagonist,potent and selective
      ≥21.08 mg/mL

Items 12721-12730 of 13618

Page
per page